NAMS
NewAmsterdam Pharma Company N.V.
$37.25
+$1.08(+2.99%)
42
Overall
50
Value
45
Tech
31
Quality
Market Cap
$3.95B
Volume
766.76K
52W Range
$14.06 - $42.00
Target Price
$46.92
EPS Estimates Overview
| Current Quarter | $-0.4 | Next Quarter | $-0.44 |
| Current Year | $-1.53 | Next Year | $-2.01 |
| QoQ Growth | -10.0% | YoY Growth | -31.4% |
| 3Y EPS CAGR | -63.3% | Target Price | $46.92 |
| Consensus | Buy | Upside | +26.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $37.25 | +3.0% | 766.76K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW